| Systematic (IUPAC) name | |
|---|---|
| 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(2-hydroxyethoxy)-3-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 23869-24-1 |
| ATC code | C05CA02 |
| PubChem | CID 9852585 |
| UNII | EKF7043SBU |
| KEGG | D07179 |
| Synonyms | Rutilemone Varemoid Paroven Relvene Monoxerutinum Monoxerutina Monoxerutine |
| Chemical data | |
| Formula | C29H34O17 |
| Mol. mass | 654.57 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
Monoxerutin is a flavonol, a type of flavonoid. It is more accurately a hydroxyethylrutoside.[1]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)